Pulmonary valve replacement for treatment of severe pulmonary regurgitation in patients with previous tetralogy of Fallot repair surgery.


Journal

Multimedia manual of cardiothoracic surgery : MMCTS
ISSN: 1813-9175
Titre abrégé: Multimed Man Cardiothorac Surg
Pays: England
ID NLM: 101495626

Informations de publication

Date de publication:
12 Apr 2023
Historique:
medline: 14 4 2023
entrez: 12 4 2023
pubmed: 13 4 2023
Statut: epublish

Résumé

Tetralogy of Fallot was classically described as the combination of pulmonary stenosis, right ventricle hypertrophy, perimembranous ventricular septal defect and an aortic root that overrides the ventricular septal defect. Full surgical repair, which is usually indicated in toddlers, comprises closure of the ventricular septal defect and alleviation of the pulmonary stenosis. Because there is a wide anatomical spectrum, the cause and severity of the pulmonary stenosis are variable. However, when the pulmonary valve is stenotic and not well-developed, it has to be removed, and one has to accept severe pulmonary regurgitation as a sequela. In the ensuing years, when signs of damage to the right ventricle are proven, pulmonary valve replacement is indicated. We present the case of a 16-year-old patient with tetralogy of Fallot that was corrected during the first year of life. Follow-up demonstrated progressive exercise intolerance and moderate-to-severe right ventricle dilatation. Thus, surgical pulmonary valve replacement was indicated. The surgical approach was through a full median redo sternotomy. Central cardiopulmonary bypass was established with bicaval drainage. The operation was performed under assisted non-clamped circulatory support. The calcified previous pericardial patch was removed, and a 25-mm bioprosthetic valve was implanted in the pulmonary annulus. A new pericardial heterologous patch was used for the transannular pulmonary plasty.

Identifiants

pubmed: 37042764
doi: 10.1510/mmcts.2023.017
doi:

Types de publication

Case Reports Video-Audio Media

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author 2023. Published by MMCTS on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Auteurs

Jesús Ruiz-Abad (J)

Department of Cardiovascular Surgery, Hospital maternoinfantil Sant Joan de Déu, Barcelona, Spain.

Madeleine A Z Ball (MAZ)

Department of Pediatric Cardiology, Hospital maternoinfantil Sant Joan de Déu, Barcelona, Spain.

Javier Mayol (J)

Department of Cardiovascular Surgery, Hospital maternoinfantil Sant Joan de Déu, Barcelona, Spain.

Stefano Congiu (S)

Department of Cardiovascular Surgery, Hospital maternoinfantil Sant Joan de Déu, Barcelona, Spain.

Bosco Moscoso (B)

Cardiovascular Surgery Department. Hospital Clínic Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH